// App-Quantinova.ai

TCT-563 : Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Researchers

Presenter

  • Stefan Verheye

Principal Investigators

  • Mark Webster

  • James Stewart

  • Alexandre Abizaid

  • Ricardo Costa

  • Jose Costa Jr

  • John Yan

  • Vinayak Bhat

  • Lynn Morrison

  • Sara Toyloy

  • John Ormiston

Medical Centers

  • ICU, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil

  • Antwerp Cardiovascular Center, ZNA Middelheim, Antwerp, Belgium, Antwerp, Belgium

  • Professor, University of Auckland Medical School, Auckland, New Zealand

  • Auckland City Hospital, Auckland, New Zealand

  • Visiting Professor Columbia University, Sao Paulo, Brazil

Locations

  • Brazil

  • Belgium

  • New Zealand

Companies

  • Elixir medical corpo

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary artery lesions

  • Venous thrombosis

Biomarkers

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved